Fintel reports that on March 7, 2025, Leerink Partners initiated coverage of CorMedix (NasdaqGM:CRMD) with a Outperform ...

D. Boral Capital restated their buy rating on shares of CorMedix (NASDAQ:CRMD – Free Report) in a report released on ...

Stock analysts at Leerink Partners started coverage on shares of CorMedix (NASDAQ:CRMD – Get Free Report) in a report ...

We feel now is a pretty good time to analyse CorMedix Inc.'s ( NASDAQ:CRMD ) business as it appears the company may be... BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc ...

The firm increased its portfolio allocation in CRMD by 114.89% over the last quarter. VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 1,732K shares representing 2.85% ...

Leerink analyst Roanna Ruiz initiated coverage of CorMedix (CRMD) with an Outperform rating and $18 price target The firm believes the ...

BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life ...

Elliott Investment Management made several portfolio moves in the fourth quarter, closing multiple options positions and shaking up the activist firm's technology exposure. Shares of CorMedix ...

CorMedix Inc, Howmet Aerospace Inc Pref, Triple Flag Precious Metals Corp. Read The Tokenist (Timothy Fries)'s latest article on Investing.com ...

BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening ...